Spur Therapeutics
Toward the next generation of gene therapy.
122 employees · est. 2015 · Stevenage, United Kingdom
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
239 employees · est. 2015 · London, United Kingdom
Orchard Therapeutics - U.S. is the larger of the two.
Side-by-Side Comparison
| Metric | Spur Therapeutics | Orchard Therapeutics - U.S. |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2015 |
| Headquarters | ||
| Headquarters | Stevenage, United Kingdom | London, United Kingdom |
| Employees | ||
| Employees | 122 | 239 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $260.50M | $485.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 6 |
| Services | ||
| Services | Not tracked yet | Development of HSC Gene Therapy, Research and Application of Gene Therapy in Genetic Diseases, Patient-centric Therapeutic Solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Families with Members Affected by Genetic Diseases, Healthcare Professionals, Medical Institutions, Researchers in Medical and Genetic Fields |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States | Gene Therapy, Hematopoietic Stem Cell Therapy, Autologous Ex Vivo Therapy, Rare Genetic Diseases, Severe Diseases, Strimvelis, Metachromatic Leukodystrophy, Wiskott-Aldrich Syndrome, Adenosine Deaminase Severe Combined Immunodeficiency, X-linked Chronic Granulomatous Disease, Beta-thalassemia, Clinical Research, Commercial-stage Biotech, Partnerships With Academic Institutions, Curative Treatments |
| Website | ||
| Website | spurtherapeutics.com | orchard-tx.com |
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options f...
About Orchard Therapeutics - U.S.
Orchard Therapeutics - U.S., established in 2015, stands as a pioneering force in the Biotechnology and Health Care sectors. As a subsidiary of Kyowa Kirin, it is devoted to transforming lives through innovative gene therapy, particularly targeting severe genetic diseases. Their approach involves th...
We will tell you when either one moves
BounceWatch watches Spur Therapeutics and Orchard Therapeutics - U.S. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Spur Therapeutics and Orchard Therapeutics -... — by email.
Frequently Asked Questions
Compare Spur Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Spur Therapeutics on 11 Sep 2024, and Orchard Therapeutics - U.S. on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.